author-photo

Zuotao Zhao

Peking University

45

Papers

325

Citations

Citation Trend

Filter By

Papers (30) Sort By

Journal Conference Others

Omalizumab in chronic inducible urticaria: A real-life study of efficacy, safety, predictors of treatment outcome and time to response.

2021 Clinical & Experimental Allergy
Show All
- Source
- Cite
- Save
Citations (1)
The prevalence and year lived with disability of atopic dermatitis in China: Findings from the global burden of disease study 2019

2021 World Allergy Organization Journal
Show All
- Source
- Cite
- Save
Citations (0)
Omalizumab Treatment and Outcomes in Chinese Patients with Chronic Spontaneous Urticaria, Chronic Inducible Urticaria, or Both

2021 The Journal of Allergy and Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Omalizumab in Chronic Inducible Urticaria: a Real-Life Study of Efficacy, Safety, Predictors of Treatment Outcome, Time to Response and Relapse

2021 The Journal of Allergy and Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both

2021 World Allergy Organization Journal
Show All
- Source
- Cite
- Save
Citations (3)
Proposal of 0.5mg of protein /100g of processed food as threshold for voluntary declaration of food allergen traces in processed food – a first step in an initiative to better inform patients and avoid fatal allergic reactions - A GA²LEN position paper

2021 Allergy
Show All
- Source
- Cite
- Save
Citations (1)
Risk factors for systemic reactions in typical cold urticaria: results from the COLD-CE study.

2021 Allergy
Show All
- Source
- Cite
- Save
Citations (0)
Chinese version of the chronic urticaria quality of life questionnaire: cultural adaptation, factor analysis, assessment of reliability and validity.

2021 Archives of Dermatological Research
Show All
- Source
- Cite
- Save
Citations (0)
Omalizumab in children and adolescents with chronic urticaria: A 16 week real-world study.

2020 Allergy
Show All
- Source
- Cite
- Save
Citations (2)
Omalizumab in children and adolescents with chronic urticaria: A 16 week real-world study

2020
Show All
- Source
- Cite
- Save
Citations (0)